Cargando…

MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+

Electronic nicotine delivery systems (ENDS) or electronic cigarettes (e-cigs) are becoming exceptionally popular in the world as an alternative to conventional nicotine cigarettes, both in smokers and people who have never smoked. Use of tobacco products is a major risk factor for diabetes and contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinoza-Derout, Jorge, Shao, Xuesi M, Bankole, Emmanuel, Hasan, Kamrul M, Mtume, Norma, Sinha-Hikim, Amiya, Friedman, Theodore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551097/
http://dx.doi.org/10.1210/js.2019-MON-162
_version_ 1783424334130315264
author Espinoza-Derout, Jorge
Shao, Xuesi M
Bankole, Emmanuel
Hasan, Kamrul M
Mtume, Norma
Sinha-Hikim, Amiya
Friedman, Theodore
author_facet Espinoza-Derout, Jorge
Shao, Xuesi M
Bankole, Emmanuel
Hasan, Kamrul M
Mtume, Norma
Sinha-Hikim, Amiya
Friedman, Theodore
author_sort Espinoza-Derout, Jorge
collection PubMed
description Electronic nicotine delivery systems (ENDS) or electronic cigarettes (e-cigs) are becoming exceptionally popular in the world as an alternative to conventional nicotine cigarettes, both in smokers and people who have never smoked. Use of tobacco products is a major risk factor for diabetes and contribute to non-alcoholic fatty liver disease (NAFLD). Nicotinamide adenine dinucleotide (NAD+) plays a critical role in regulating metabolism and aging. Our laboratory has shown that ENDS induces lipolysis and NAFLD in Apolipoprotein E Knockout (ApoE(-/-)). We developed an ENDS exposure model that delivers nicotine in a manner similar to that of human ENDS users. ApoE(-/-) mice were exposed to saline, ENDS without nicotine [ENDS (0%)] and ENDS with 2.4% nicotine [(ENDS (2.4%)] aerosol for 12 weeks. Mice exposed to ENDS (2.4%) had increased apurinic/apyrimidinic (AP) sites (a manifestation of DNA damage) associated with a decreased NAD+/NADH ratio in the liver, in comparison with saline and ENDS (0%). Western blot analysis shows that mice treated with ENDS (2.4%) had increased poly(ADP-ribose) polymerases 1 (PARP-1) activity associated with reduced levels of Sirtuin 1 (SIRT1). Furthermore, hepatic oxidative stress and mitochondrial DNA mutations were increased in mice treated with ENDS (2.4%). These results demonstrate adverse effects of ENDS leading to NAD+ deficiency which is a common central pathological factor of a number of metabolic- and aging-associated diseases.
format Online
Article
Text
id pubmed-6551097
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65510972019-06-13 MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+ Espinoza-Derout, Jorge Shao, Xuesi M Bankole, Emmanuel Hasan, Kamrul M Mtume, Norma Sinha-Hikim, Amiya Friedman, Theodore J Endocr Soc Diabetes Mellitus and Glucose Metabolism Electronic nicotine delivery systems (ENDS) or electronic cigarettes (e-cigs) are becoming exceptionally popular in the world as an alternative to conventional nicotine cigarettes, both in smokers and people who have never smoked. Use of tobacco products is a major risk factor for diabetes and contribute to non-alcoholic fatty liver disease (NAFLD). Nicotinamide adenine dinucleotide (NAD+) plays a critical role in regulating metabolism and aging. Our laboratory has shown that ENDS induces lipolysis and NAFLD in Apolipoprotein E Knockout (ApoE(-/-)). We developed an ENDS exposure model that delivers nicotine in a manner similar to that of human ENDS users. ApoE(-/-) mice were exposed to saline, ENDS without nicotine [ENDS (0%)] and ENDS with 2.4% nicotine [(ENDS (2.4%)] aerosol for 12 weeks. Mice exposed to ENDS (2.4%) had increased apurinic/apyrimidinic (AP) sites (a manifestation of DNA damage) associated with a decreased NAD+/NADH ratio in the liver, in comparison with saline and ENDS (0%). Western blot analysis shows that mice treated with ENDS (2.4%) had increased poly(ADP-ribose) polymerases 1 (PARP-1) activity associated with reduced levels of Sirtuin 1 (SIRT1). Furthermore, hepatic oxidative stress and mitochondrial DNA mutations were increased in mice treated with ENDS (2.4%). These results demonstrate adverse effects of ENDS leading to NAD+ deficiency which is a common central pathological factor of a number of metabolic- and aging-associated diseases. Endocrine Society 2019-04-30 /pmc/articles/PMC6551097/ http://dx.doi.org/10.1210/js.2019-MON-162 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Diabetes Mellitus and Glucose Metabolism
Espinoza-Derout, Jorge
Shao, Xuesi M
Bankole, Emmanuel
Hasan, Kamrul M
Mtume, Norma
Sinha-Hikim, Amiya
Friedman, Theodore
MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
title MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
title_full MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
title_fullStr MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
title_full_unstemmed MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
title_short MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
title_sort mon-162 hepatic dna damage induced by ends is associated with decreased levels of nad+
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551097/
http://dx.doi.org/10.1210/js.2019-MON-162
work_keys_str_mv AT espinozaderoutjorge mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad
AT shaoxuesim mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad
AT bankoleemmanuel mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad
AT hasankamrulm mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad
AT mtumenorma mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad
AT sinhahikimamiya mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad
AT friedmantheodore mon162hepaticdnadamageinducedbyendsisassociatedwithdecreasedlevelsofnad